High-resolution melting-based quantitative analysis of rassf1 methylation in breast cancer

Medicina (Lithuania)

Volumn 49, Issue 2, 2013, Pages 78-83

  Stuopelyte, Kristina ^a   Daniunaite, Kristina ^a   Laurinavičiene, Aida ^a   Ostapenko, Valerijus ^a   Jarmalaite, Sonata ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Breast cancer; DNA methylation; HRM; QMSP; RASSF1 gene.

Indexed keywords

RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DNA DENATURATION; DNA METHYLATION; EVALUATION STUDY; FEMALE; GENETICS; HUMAN; METHODOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSITION TEMPERATURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; TRANSITION TEMPERATURE; TUMOR SUPPRESSOR PROTEINS;

EID: 84884238332     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina49020014     Document Type: Article

References (25)

1. Lithuanian Cancer Registry; 2011 [cited Nov 5, 2012]. Available from: URL: http://www.vuoi.lt/index.php?1606 197940.
2. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009; 20(8):1319-29.
3. Lettini AA, Guidoboni M, Fonsatti E, Anzalone1 L, Cortini E, Maio M. Epigenetic remodelling of DNA in cancer. Histol Histopathol 2007;22:1413-24.
4. Goedecke S, Scholosser S, Mühlisch J, Hempel G, Frühwald MC, Wünsch B. Determination of DNA methylation by COBRA: a comparative study of CGE with LIF detection and conventional gel electrophoresis. Electrophoresis 2009; 30(17):3063-70.
5. Ehrick M, Bocker S, van den Boom D. Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Res 2005;33(4):e38.
6. Reed K, Poulin ML, Yan L, Parissenti AM. Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation. Anal Biochem 2010; 397(1):96-106.
7. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28(8):e32.
8. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35(6):e41.
9. Agathanggelou A, Cooper WN, Latif F. Role of the Rasassociation domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005;65(9):3497-508.
10. Amin KS, Banerjee PP. The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog 2012; 11(3):31-8.
11. Pfeifer GP, Damman R. Methylation of the tumor suppresor gene RASSF1 in human tumors. Biochemistry (Mosc) 2005;70(5):699-707.
12. van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, Van Dam P, et al. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes. Cancer Biol Ther 2009;8(23):2252-9.
13. Buhmeida A, Merdad A, Al-Maghrabi J, Al-Thobaiti F, Ata M, Bugis A, et al. RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency. Anticancer Res 2011;31(9):2975-81.
14. Martins AT, Monteiro P, Ramalho-Carvalho J, Costa VL, Dinis-Ribeiro M, Leal C, et al. High RASSF1A promoter methylation levels are predictive of poor prognosis in fineneedle aspirate washings of breast cancer lesions. Breast Cancer Res Treat 2011;129(1):1-9.
15. Park SY, Kwon HJ, Lee HE, Ryu HS, Kim S-W, Kim JH, et al. Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch 2011;458(1):73-84.
16. Cho YH, Shen J, Gammon MD, Zhang Y-J, Wang Q, Gonzalez K, et al. Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat 2012;131(1):197-205.
17. Huang KT, Dobrovic A, Fox SB. No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer. BMC Res Notes 2009;2:194.
18. Wojdacz TK, Threstrup BB, Jens Overgaard J, Hansen LL. Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patients as two independent events. Diagn Pathol 2011;6:116.
19. Avraham A, Uhlmann R, Shperber A, Birnbaum M, Sandbank J, Sella A, et al. Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer 2012;131(7):E1166-72.
20. Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol 2012;7:27.
21. Vinci S, Gelmini S, Mancini I, Malentachi F, Pazzagli M, Beltrami C, et al. Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods 2013; 59(1):138-46.
22. Gonzalgo ML, Yegnasubramanian, Yan G, Rogers CG, Nicol TL, Nelson WG. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis. Clin Cancer Res 2004;10:7276-83.
23. Herman JG, Graff JR, Myöhönen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93(18):9821-6.
24. Amornpisutt R, Sriraksa R, Limpaiboon T. Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma. Clin Biochem 2012;45(13-14):1092-4.
25. Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussière M, Lesimple T, etal. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive highresolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients. Cancer 2012;118(17):4201-11.